THROMBOXANE-A2 PROSTAGLANDIN-H2 MOBILIZES CALCIUM IN HUMAN-BLOOD PLATELETS
THROMBOXANE-A2 PROSTAGLANDIN-H2 MOBILIZES CALCIUM IN HUMAN-BLOOD PLATELETS
复制标题
DOI:
10.1152/ajpheart.1985.249.1.h1
复制
发表时间:
1985-01-01
影响因子:
--
通讯作者:
LEBRETON, GC
中科院分区:
文献类型:
--
作者:
BRACE, LD;VENTON, DL;LEBRETON, GC
The mechanism by which thromboxane A2/prostaglandin H2 (TXA2/PGH2) stimulates platelet activation was investigated. Apparently TXA2/PGH2 functions to release Ca from intraplatelet stores. It was investigated whether TXA2/PGH2 causes mobilization of Ca in intact platelets. Ca redistribution was measured using the fluorescent probe, chlortetracycline (CTC), and a photon-counting microspectrofluorometer. Human platelet-rich plasma was incubated with CTC (50 .mu.M) for 40 min at 25.degree. C. Shape change was induced with arachidonic acid (AA, 100 .mu.M) or ADP (0.75-1.0 .mu.M). AA addition resulted in a significant release of intraplatelet Ca. This release was blocked by inhibition of the cyclooxygenase with indomethacin (20 .mu.M) or the specific TXA2/PGH2 antagonist, 13-azaprostanoic acid (13-APA, 100 .mu.M). Neither indomethacin nor 13-APA had any effect on Ca release stimulated by ADP. Prostacyclin (13 nM) inhibited both AA- and ADP-induced Ca release. These findings provide evidence that cyclooxygenase products of AA, i.e., TXA2 and/or PGH2, directly caused the mobilization of intraplatelet Ca. This Ca mobilization appears to be mediated through a specific TXA2/PGH2 receptor interaction.